“However, imposing broad and unfocused tariffs on products like the subject chemical used to produce a U.S. made drug critical to the treatment of a disease will only serve to discourage U.S. manufacturing, risk increasing health care costs, and jeopardize cancer treatment. These are consequences that will result in disproportionate economic harm to U.S. interests.”